Stay updated on Bispecific Antibody MCLA-158 Clinical Trial

Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    No meaningful content changes detected between the two screenshots; no additions or deletions affecting core content, navigation, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-28T05:30:13.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    - Added a government funding/operating status notice and a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed the resource: Genetic and Rare Diseases Information Center resources: Carcinoma of esophagus (v3.1.0).
    Difference
    2%
    Check dated 2025-10-06T16:11:00.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated contact details and new software revision (v3.1.0) replace an old disease term and older revision (v3.0.2).
    Difference
    0.2%
    Check dated 2025-09-29T10:24:37.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page version updated from v3.0.1 to v3.0.2, indicating a minor release. The 'Back to Top' navigation element was removed.
    Difference
    0.1%
    Check dated 2025-09-15T01:08:28.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T21:38:05.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific drug information for Pembrolizumab and detailed resources related to various gastrointestinal diseases, while also removing some location-related terms and previous drug classifications.
    Difference
    3%
    Check dated 2025-08-31T19:52:07.000Z thumbnail image

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.